Related Experiment Videos
ClC-3: more than just a volume-sensitive Cl- channel
Carmelle V Remillard1, Jason X-J Yuan
1Department of Medicine, School of Medicine, University of California, 9500 Gilman Drive, San Diego, La Jolla, CA 92093-0725, USA.
British Journal of Pharmacology
|February 22, 2005
Summary
The ClC-3 chloride channel is upregulated in pulmonary hypertension, promoting smooth muscle cell survival and vascular remodeling. This finding offers new insights into pulmonary arterial hypertension mechanisms.
Area of Science:
- Cardiovascular Research
- Ion Channel Physiology
- Pulmonary Hypertension Pathophysiology
Background:
- Pulmonary arterial hypertension (PAH) involves pulmonary artery smooth muscle cell (PASMC) proliferation and reduced apoptosis, leading to increased vascular resistance.
- Altered transmembrane ion flux through ion channels is implicated in PAH pathogenesis.
- While cation channels have been extensively studied, the role of anion efflux via chloride (Cl-) channels in PASMC function is gaining attention.
Discussion:
- Dai et al. demonstrate that the ClC-3 chloride channel is upregulated in PASMCs from rats with monocrotaline-induced pulmonary hypertension and in canine PASMCs treated with inflammatory cytokines.
- Evidence suggests that ClC-3 upregulation may confer protection against oxidative stress-induced PASMC necrosis.
- This protective effect on PASMC survival contributes to the medial hypertrophy characteristic of PAH.
Key Insights:
- The volume-sensitive ClC-3 channel is a key player in pulmonary vascular remodeling in PAH.
- ClC-3 upregulation appears to be a survival mechanism for PASMCs under stress.
- Targeting ClC-3 may offer a novel therapeutic strategy for PAH.
Outlook:
- Further investigation into the precise mechanisms by which ClC-3 influences PASMC survival and proliferation is warranted.
- Exploring the therapeutic potential of modulating ClC-3 activity in PAH treatment.
- Understanding the interplay between ClC-3 and other ion channels in PAH pathogenesis.